These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28046052)

  • 1. Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients.
    Picat MQ; Pellegrin I; Bitard J; Wittkop L; Proust-Lima C; Liquet B; Moreau JF; Bonnet F; Blanco P; Thiébaut R;
    PLoS One; 2017; 12(1):e0169164. PubMed ID: 28046052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort.
    Wittkop L; Bitard J; Lazaro E; Neau D; Bonnet F; Mercie P; Dupon M; Hessamfar M; Ventura M; Malvy D; Dabis F; Pellegrin JL; Moreau JF; Thiébaut R; Pellegrin I;
    J Infect Dis; 2013 Feb; 207(4):622-7. PubMed ID: 23204178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study.
    Valiathan R; Miguez MJ; Patel B; Arheart KL; Asthana D
    PLoS One; 2014; 9(5):e97698. PubMed ID: 24842313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
    Pinacchio C; Scagnolari C; Iebba V; Santinelli L; Innocenti GP; Frasca F; Bitossi C; Scordio M; Oliveto G; Ceccarelli G; Antonelli G; Mastroianni CM; d'Ettorre G
    AIDS; 2020 Aug; 34(10):1467-1473. PubMed ID: 32675560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells.
    Fernandez S; Tanaskovic S; Helbig K; Rajasuriar R; Kramski M; Murray JM; Beard M; Purcell D; Lewin SR; Price P; French MA
    J Infect Dis; 2011 Dec; 204(12):1927-35. PubMed ID: 22006994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
    Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
    BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.
    Marchetti G; Nasta P; Bai F; Gatti F; Bellistrì GM; Tincati C; Borghi F; Carosi G; Puoti M; Monforte Ad
    PLoS One; 2012; 7(2):e32028. PubMed ID: 22363790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression.
    Rousseau RK; Szadkowski L; Kovacs CM; Saikali MF; Nadeem R; Malazogu F; Huibner S; Cummins CL; Kaul R; Walmsley SL
    PLoS One; 2021; 16(7):e0254149. PubMed ID: 34320023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.
    Karim R; Mack WJ; Kono N; Tien PC; Anastos K; Lazar J; Young M; Desai S; Golub ET; Kaplan RC; Hodis HN; Kovacs A
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):349-56. PubMed ID: 25314253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
    Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy.
    Zheng L; Taiwo B; Gandhi RT; Hunt PW; Collier AC; Flexner C; Bosch RJ
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):153-60. PubMed ID: 25072610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells.
    Cockerham LR; Siliciano JD; Sinclair E; O'Doherty U; Palmer S; Yukl SA; Strain MC; Chomont N; Hecht FM; Siliciano RF; Richman DD; Deeks SG
    PLoS One; 2014; 9(10):e110731. PubMed ID: 25340755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.